The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Coffee, CYP1A2 Genotype, and Risk of Myocardial Infarction
Open accessAbstract
CONTEXT: The association between coffee intake and risk of myocardial infarction (MI) remains controversial. Coffee is a major source of caffeine, which is metabolized by the polymorphic cytochrome P450 1A2 (CYP1A2) enzyme. Individuals who are homozygous for the CYP1A2*1A allele are "rapid" caffeine metabolizers, whereas carriers of the variant CYP1A2*1F are "slow" caffeine metabolizers. OBJECTIVE: To determine whether CYP1A2 genotype modifies the association between coffee consumption and risk of acute nonfatal MI. DESIGN, SETTING, AND PARTICIPANTS: Cases (n = 2014) with a first acute nonfatal MI and population-based controls (n = 2014) living in Costa Rica between 1994 and 2004, matched for age, sex, and area of residence, were genotyped by restriction fragment-length polymorphism polymerase chain reaction. A food frequency questionnaire was used to assess the intake of caffeinated coffee. MAIN OUTCOME MEASURE: Relative risk of nonfatal MI associated with coffee intake, calculated using unconditional logistic regression. RESULTS: Fifty-five percent of cases (n = 1114) and 54% of controls (n = 1082) were carriers of the slow *1F allele. For carriers of the slow *1F allele, the multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of nonfatal MI associated with consuming less than 1, 1, 2 to 3, and 4 or more cups of coffee per day were 1.00 (reference), 0.99 (0.69-1.44), 1.36 (1.01-1.83), and 1.64 (1.14-2.34), respectively. Corresponding ORs (95% CIs) for individuals with the rapid *1A/*1A genotype were 1.00, 0.75 (0.51-1.12), 0.78 (0.56-1.09), and 0.99 (0.66-1.48) (P = .04 for gene x coffee interaction). For individuals younger than the median age of 59 years, the ORs (95% CIs) associated with consuming less than 1, 1, 2 to 3, or 4 or more cups of coffee per day were 1.00, 1.24 (0.71-2.18), 1.67 (1.08-2.60), and 2.33 (1.39-3.89), respectively, among carriers of the *1F allele. The corresponding ORs (95% CIs) for those with the *1A/*1A genotype were 1.00, 0.48 (0.26-0.87), 0.57 (0.35-0.95), and 0.83 (0.46-1.51). CONCLUSION: Intake of coffee was associated with an increased risk of nonfatal MI only among individuals with slow caffeine metabolism, suggesting that caffeine plays a role in this association.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Panel notes that, although this case-control study suggests that polymorphisms of the CYP1A2 gene may affect the risk of MI in relation to caffeine consumption, which may be further affected by polymorphisms of the serotonin receptor gene HTR2A, the results have not yet been replicated and the hypothesis has not been tested in prospective cohort studies.”
From Scientific Opinion on the safety of caffeine (2015) · cites this paper as Cornelis et al., 2006
In the citing paper
“In total, 55 % of cases (n = 1 114) and 54 % of controls (n = 1 082) were carriers of the slow *1F allele, for which the multivariate-adjusted odds ratios (ORs) and 95 % CIs for non-fatal MI associated with the consumption of less than one, one, two to three and four or more cups of coffee per day were 1.00 (reference), 0.99 (0.69-1.44), 1.36 (1.01-1.83)and 1.64 (1.14-2.34),respectively.Cor”
From Scientific Opinion on the safety of caffeine (2015) · cites this paper as Cornelis et al., 2006
In the citing paper
“A study by Cornelis MC et al.47 showed that CYP1A2 genotype was an effect modifier between coffee consumption and risk of myocardial infarction: coffee consumption was related to higher risk of myocardial infarction for the slow caffeine metabolizer, and was not related to myocardial infarction for the fast caffeine metabolizer.”
From Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose–Response Meta-Analysis of Prospective Cohort Studies (2014) · cites this paper as [47]
In the citing paper
“However, this analysis was based on a case-control study conducted in Costa Rico and the results have not been replicated in prospective cohort studies yet.”
From Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose–Response Meta-Analysis of Prospective Cohort Studies (2014) · cites this paper as [47]
Citations
Cites
Willett, W. C. (1998) · doi:10.1093/acprof:oso/9780195122978.001.0001 · Cited by 4,541
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A.-M., & Pająk, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,260
Effects of caffeine on human health
Nawrot, P., Jordan, S., Eastwood, J., Rotstein, J., Hugenholtz, A., & Feeley, M. (2003) · Food Additives and Contaminants · doi:10.1080/0265203021000007840 · Cited by 1,199
Sachse, C., Brockmöller, J., Bauer, S., & Roots, I. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00898.x · Cited by 751
How introns influence and enhance eukaryotic gene expression
Hir, H. L., Nott, A., & Moore, M. J. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00052-5 · Cited by 734
Butler, M. A., Iwasaki, M., Guengerich, F. P., & Kadlubar, F. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7696 · Cited by 638
Shryock, J. C., & Belardinelli, L. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00256-7 · Cited by 578
Caffeine as a psychomotor stimulant: mechanism of action
Fisone, G., Borgkvist, A., & Usiello, A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3269-3 · Cited by 558
Nakajima, M., Yokoi, T., Mizutani, M., Kinoshitah, M., Funayama, M., & Kamataki, T. (1999) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022352 · Cited by 345
Gu, L., Gonzalez, F. J., KALOW, W., & Tang, B. K. (1992) · Pharmacogenetics · doi:10.1097/00008571-199204000-00004 · Cited by 326
Cited by
Sorted by citations
Items 401–497 of 497
How does Nutrigenetics Influence Long-Term Health?
Kohlmeier, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385900-6.00005-8 · Cited by 1
Kohlmeier, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-387784-0.00004-3 · Cited by 1
Danielsson, J. (2014) · Tampere University Institutional Repository (Tampere University) · Cited by 1
From Molecular Nutrition to Nutritional Systems Biology
Vergères, G. (2009) · Epigenetics and human health · doi:10.1002/9783527628384.ch10 · Cited by 1
Genetic Variation and Nutrient Metabolism
Cahill, L. E., & El‐Sohemy, A. (2012) · Wiley eBooks · doi:10.1002/9781119946045.ch3 · Cited by 1
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.332 · Cited by 1
Hallström, H. (2013) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Muller, P. J. (2015) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
Framing Nutrigenomics for Individual and Public Health: Public Representations of an Emerging Field
Caulfield, T., Shelley, J., Bubela, T. M., & Minaker, L. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374125-7.00012-6 · Cited by 1
Cytochrome P450 isoform genotyping in poor propranolol responders for hemangioma treatment
He, A., Khanna, R., & Kwatra, S. G. (2017) · Pediatrics International · doi:10.1111/ped.13162 · Cited by 1
Disclosure of Genetic Information for Personalized Nutrition and Change in Dietary Intake
Nielsen, D. E. (2014) · TSpace (University of Toronto) · Cited by 1
Coffee Drinking and Risk of All-Cause Mortality and Cardiovascular Diseases
Hirakawa, Y. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0157 · Cited by 1
Sex Differences in Cardiovascular Drug Response
Rodenburg, E. M. (2012) · RePub (Erasmus University Rotterdam)
Pharmakologie noradrenerger und adrenerger Systeme – Pharmakotherapie des Asthma bronchiale – Doping
Starke, K. (2013) · Elsevier eBooks · doi:10.1016/b978-3-437-42523-3.00004-x
Coffee mixes badly with certain genes
Pearson, H. (2006) · Nature · doi:10.1038/news060306-9
Farmacogenética: hacia la individualización de la terapia farmacológica en Costa Rica
Costarricense, A. M., de Médicos, C., Arrieta‐Bolaños, E., Alvarado-Ulate, P., Baudrit-Carrillo, O., & Salazar‐Sánchez, L. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The Health Lowdown on Caffeine
Alpert, P. T. (2012) · Home Health Care Management & Practice · doi:10.1177/1084822311435543
Meijer, P., Oyen, W. J. G., Dekker, D., van den Broek, P. H. H., Wouters, C. W., Boerman, O. C., Scheffer, G. J., Smits, P., & Rongen, G. A. P. J. M. (2008) · Artery Research · doi:10.1016/j.artres.2008.08.315
Cornelis, M. C., El‐Sohemy, A., & Campos, H. (2007)
Achour, A., Maman, I., Gahbiche, A., Bouraoui, H., Ben, F., Slama, H., & Zemni, R. (2011)
Allele Frequency and Genotype Distribution of 9 SNPs in the Kazakh
Iskakova, P., Romanova, A. A., Voronina, E. N., Sikhayeva, N. S., Belozerceva, L. A., Филипенко, М. Л., Erlan, M., Llp, G. G., & Iskakova, A. N. (2014)
Gosselin, C. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-5130
Preventive Effects of Food Factors on Atherosclerotic Diseases
Hirano-Ohmori, R. (2007) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.60.3
Greater Risk for MI in Coffee Drinkers with Slow Caffeine Metabolism
Marx, J. A., Faaem, & Facep (2006) · Journal watch · doi:10.1056/em200605090000011
(2010) · The Internet Journal of Health · doi:10.5580/95d
“For people who are genetically slow metabolizers of caffeine, drinking coffee significantly raises the risk of developing a heart attack, or experiencing a myocardial infarction [3].”
BackgroundHow Can we Know What the Latest Findings Mean?
Kohlmeier, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385900-6.00006-x
Egger, G. J., & Pearson, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810401-9.00009-7
Costarricense, A. M., de Médicos, C., Arrieta‐Bolaños, E., Alvarado-Ulate, P., Baudrit, O., & Salazar‐Sánchez, L. (2012)
Summaries of the Micronutrient Symposium of the 2016 Meeting of the American College of Nutrition
El‐Sohemy, A., Brewer, G. J., & Prasad, A. S. (2017) · Journal of the American College of Nutrition · doi:10.1080/07315724.2017.1305256
Coffee and Risk of Cardiovascular Disease
di Giuseppe, R., Wirth, J., & Weikert, C. (2014) · Coffee in Health and Disease Prevention · doi:10.1016/b978-0-12-409517-5.00041-3
Evolving Dietetics Education to Respond to Emerging Technologies in Nutritional Genomics
Colson, N., & Adamski, M. M. (2017) · Advances in educational technologies and instructional design book series · doi:10.4018/978-1-5225-3850-9.ch004
A Regression-based Framework for Scalable Pathway-guided Search in Genome-wide Association StudiesPreprint
Biswas, S., Pal, S., & Bhattacharjee, S. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/241265
“These were IL13 for psoriasis, 2 loci (near BLK and ITGAM/ITGAX genes) for SLE, at least 2 loci (near PECAM1 and CXCL12 genes) for CAD and 6 loci (near THADA, KCNQ1, ARAP1, MTNR1B, HMGA2 and C2CD4A genes respectively) for T2DM.”
BackgroundInfluentialFlüssigkeitszufuhr, Fitness und Fettleibigkeit
Egger, G. J., Sagner, M., & Pearson, S. (2017) · Elsevier eBooks · doi:10.1016/b978-3-437-23274-9.00009-5
Nutrigenetik in Theorie und Praxis
Madenach, M., Kolossa, S., & Gedrich, K. (2018) · Aktuelle Ernährungsmedizin · doi:10.1055/a-0643-3871
“C-Allel-Träger des CYP1A2-Gens sollten demnach ihren Koffeinkonsum einschränken, um das Krankheitsrisiko für einen Herzinfarkt zu verringern.”
BackgroundInfluentialThe Alleged Health-Protective Effects of Coffee
García‐Bailo, B., Guest, N. S., & El‐Sohemy, A. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.5807
Caffeine in Beverages: Cardiovascular Effects
Mattioli, A. V., Puviani, M. B., & Farinetti, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815864-7.00008-8
The future of genetically based nutritional and pharmacological ergogenic aids in sport
Guest, N. S., García‐Bailo, B., Eny, K. M., Joffre, S., & El‐Sohemy, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816193-7.00020-8
Pharmaconutrigenetics: The Impact of Genetics on Nutrient–Drug Interactions
Dong, O. M., & Wiltshire, T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-804572-5.00068-9
Preparing for Our Enhanced Future
Farrelly, C. (2007) · Journal of Medical Regulation · doi:10.30770/2572-1852-93.2.12
Drug-Related Diseases of the Coronary Artery
Rezkalla, S. H., & Kloner, R. A. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_65
Drug-Related Diseases of the Coronary Artery
Rezkalla, S. H., & Kloner, R. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_65-1
Aguilar-Salinas, C. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.729078595.793558326
(EFSA), E. F. S. A. (2015) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2015.en-811
Is coffee a nutraceutical or a risk?
(2006) · Arbor Clinical Nutrition Updates · doi:10.1017/s1446545000000786
Vassalotti, J. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-30892-6_5
Yang, P. Y. T., Williams, M. S., Gibson, R., & Rodriguez‐Mateos, A. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165450-00083
Aiello, J. J., Nagelkirk, P. R., Sackett, J. R., Fitzgerald, L. F., Hargens, T. A., Saunders, M. J., El‐Sohemy, A., & Womack, C. J. (2022) · The Journal of Sports Medicine and Physical Fitness · doi:10.23736/s0022-4707.22.14323-9
Coffee substitutes from regional wild and cultivated plants
Baibusinova, A. K., Kabieva, S. J., & Tarasovskaya, N. E. (2024) · The Journal of Almaty Technological University · doi:10.48184/2304-568x-2024-1-101-110
Preliminary study: nutrigenomics analysis results of COVID-19 survivors
Veterini, A. S., Semedi, B. P., Airlangga, P. S., Firdaus, K. M., Uhud, A. N., Kriswidyatomo, P., & Sumara, R. (2024) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-024-00547-w
“The group of people with slow metabolizer qualifications has a greater risk of myocardial infarction than the fast metabolism group [48].”
BackgroundDeath Due to Caffeine and Methamphetamine Toxicity: A Case Report
Kim, D. G., Powers, S., & Gitto, L. (2024) · Cureus · doi:10.7759/cureus.66634
“Those with genetically slower caffeine metabolism may experience prolonged effects and heightened sensitivity to caffeine, potentially increasing the risk of conditions like myocardial infarction [12].”
BackgroundPopa, L. C., Farcaş, S. S., & Andreescu, N. I. (2024) · Research Square · doi:10.21203/rs.3.rs-4963863/v1
A Comprehensive Review of Coffee's Health Impacts on Older Adults
Lyu, W., & Jia, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13868-3.00064-8
Kafeina, gjenotipet e cyp1a2 dhe rreziku i infarktit të miokardit
Zeneli, S., & Dama, A. (2024) · Optime · doi:10.55312/op.vi2.4369
Unpacking the impacts of caffeine containing energy drinks on athletic performance
Martin, J., & Shearer, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13803-4.00008-2
Genetik ve Beslenme: Performans Optimizasyonunda Beslenme
Kılınç, H. (2025) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub706.c3009
Ma, X.-B., Lv, Y.-L., Lin, Q., Yang, J.-F., Song, Q., & Liu, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1453106
Effects of Lifestyle Interventions on Metabolic Dysfunction-Associated Steatotic Liver Disease
Sharma, A. R., & Barb, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-82888-1_10
Djordjevic, N. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166853-00341
Zheng, S., Guo, D., Pang, Q., Liu, S., Liu, C., Wu, Y., Wang, W., Yang, X., & Huang, H. (2025) · Research Square · doi:10.21203/rs.3.rs-6590720/v1
Vassalotti, J. A., & Chhaya, R. (2025) · Nutrition and health · doi:10.1007/978-3-031-87441-3_8
Genomics and Oral Health: An Overview
DeBusk, R. M. (2014) · Springer eBooks · doi:10.1007/978-1-60761-490-6_10
Zhang, S., Niu, Q., Tong, L. X., Liu, S., Wang, P., Xu, H., Li, B., & Zhang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26605522
Zhang, S., Niu, Q., Tong, L. X., Liu, S., Wang, P., Xu, H., Li, B., & Zhang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26605525
Zhang, S., Niu, Q., Tong, L. X., Liu, S., Wang, P., Xu, H., Li, B., & Zhang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26605507
Zhang, S., Niu, Q., Tong, L. X., Liu, S., Wang, P., Xu, H., Li, B., & Zhang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26605519
Zhang, S., Niu, Q., Tong, L. X., Liu, S., Wang, P., Xu, H., Li, B., & Zhang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26605510
Roa‐Díaz, Z. M., Teuscher, J., Gamba, M., Bundo, M., Grisotto, G., Wehrli, F., Gamboa, E., Rojas, L. Z., Gómez-Ochoa, S. A., Verhoog, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20522655
Zhang, S., Niu, Q., Tong, L. X., Liu, S., Wang, P., Xu, H., Li, B., & Zhang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26605504
Additional file 1 of Coffee intake and hypertension in Korean adults: results from KNHANES 2012–2016
Shah, S., Cho, I.-J., Lee, W., PYUN, W. B., & Ha, E. (2023) · Figshare · doi:10.6084/m9.figshare.23689544
Zhang, S., Niu, Q., Tong, L. X., Liu, S., Wang, P., Xu, H., Li, B., & Zhang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26605516
Roa‐Díaz, Z. M., Teuscher, J., Gamba, M., Bundo, M., Grisotto, G., Wehrli, F., Gamboa, E., Rojas, L. Z., Gómez-Ochoa, S. A., Verhoog, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20522652
Zhang, S., Niu, Q., Tong, L. X., Liu, S., Wang, P., Xu, H., Li, B., & Zhang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26605534
Zhang, S., Niu, Q., Tong, L. X., Liu, S., Wang, P., Xu, H., Li, B., & Zhang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26605531
Zhang, S., Niu, Q., Tong, L. X., Liu, S., Wang, P., Xu, H., Li, B., & Zhang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26605513
Zhang, S., Niu, Q., Tong, L. X., Liu, S., Wang, P., Xu, H., Li, B., & Zhang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26605528
THE IMPACT OF COFFEE CONSUMPTION ON HUMAN HEALTH: A REVIEW OF SCIENTIFIC EVIDENCE
Adamik, M., Barwacz, J., Gładysz, D., Settaf-Cherif, L., Malinowska, K., & Settaf-Cherif, E. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4192
Nutrition‐Induced Changes at Molecular Level
Sanghi, D., Sharma, M., & Sharma, A. (2026) · doi:10.1002/9781394293148.ch6
Lin, Y., Shi, Y., Chen, L., Chen, Z., Zhong, H., Zhong, Y., Zeng, R., Chen, X., Lin, F., & Cai, G. (2026) · Nutrition Journal · doi:10.1186/s12937-026-01291-0 · Cited by 1
Jung, S. H., & Park, Y. K. (2026) · Healthcare · doi:10.3390/healthcare14060766
Qiao, X., Toma, V. W., Wang, J., Herráiz-Adillo, Á., Söderholm, S., Berglind, D., Calling, S., Daka, B., Martinell, M., Bergman, F., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-44122-2
“A case control study of Hispanic American descent ( n = 4028) suggested that the risk of nonfatal MI depended on the ability to metabolize caffeine and that the carriers of variant CYP1A2*1F, the slow metabolizers, had an increased risk of MI with higher coffee consumption 22 .”
Consumo de café y riesgo cardiovascular en síndrome metabólico: revisión sistemática y metaanálisis
Maldonado, Y. V. R., Ayala, J. A. G., Gómez, J. Y. A., & Torra, S. F. O. (2026) · RESPYN Revista de Salud Pública y Nutrición · doi:10.29105/respyn25.1-889
Lefèvre‐Arbogast, S. (2019) · theses.fr (ABES) · doi:10.70675/6915e632z663fz4caaz9c7az455ad25755da
Amjad, G., Saif, R., & Hussain, M. G. (2026) · Futuristic Biotechnology · doi:10.54393/fbt.v6i1.225
Debating coffee and hypertension: coffee may increase the risk for chronic hypertension
Palatini, P. (2026) · American Journal of Hypertension · doi:10.1093/ajh/hpag017
Dhawan, A., Khan, S. M., Fennell, M. L., Cho, C. Y., Monk, J. M., & Keathley, J. (2026) · Nutrients · doi:10.3390/nu18111811
“…genetic variation (i.e., “fast” vs. “slow” caffeine metabolizers), when caffeine intake exceeds the equivalent of approximately 2–3 cups of coffee per day, “slow metabolizers” of caffeine are at a significantly higher risk of cardiovascular and renal disease compared to “fast metabolizers” [2,3].”
Xu, Y., Huang, Y., Wang, N., Chen, E., Zhou, X., Yuan, B., & Xia, Z. (2026) · Cogent Food & Agriculture · doi:10.1080/23311932.2026.2683122
CAFFEINE AS A CARDIOPROTECTIVE AND CARDIOTOXIC AGENT: A REVIEW OF RECENT EVIDENCE
Kossmann, M., Szalewska, L., Abdulgater, A., Osuch-Tomaszewska, P., Urowska, W., Łysiak, J., & Kazubek-Fuksiewicz, I. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5440
“Genetics, especially CYP1A2-related variation, may influence caffeine clearance and prolong exposure in slower metabolizers (Cornelis et al., 2006; Palatini et al., 2009).”
InfluentialSchwarz, S., & Lachenmeier, D. W. (2026) · Beverages · doi:10.3390/beverages12100117
“Caffeine sensitivity itself is partly heritable and depends on CYP1A2 polymorphisms [106–110], with consequences for both cardiovascular outcomes [106] and habitual consumption [109].”
Genomic Insights and Athletic Excellence: Advancing Inclusivity in India’s Sports Development
Rekha, S., & Usha, B. (2026) · Springer eBooks · doi:10.1007/978-981-92-1978-0_9
Jiang, Z., & Ding, Y. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08662-5 · Cited by 1
Tiongco, R. E., Basilio, P. V., Dequiros, R. A., Dominguez, M. J., Flores, J. A., Manansala, N. T., Masiclat, S., Tiam-Lee, C., & Navarro, A. T. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02562-x
“In addition, interindi - vidual differences in caffeine metabolism, including genetic polymorphisms in the CYP1A2 gene, may contribute to variability in caffeine exposure despite similar reported intake [ 42 – 44 ].”
Meng, T.-Z., & Nielsen, D. E. (2026) · Journal of NutriLife · doi:10.1016/j.tjnut.2026.101798
Babian, C., & Kumar, S. (2026) · The American Biology Teacher · doi:10.1525/abt.2026.88.7.352
Kofeina jej zalety i działanie niepożądane
Tomaszewski, M., Tomaszewska, M., & Olchowik, G. (2013)
Metadata
- Authors
- Cornelis, M. C., El-Sohemy, A., Kabagambe, E. K., & Campos, H.
- Affiliations
- University of Toronto (CA)
- Harvard University (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-03-08
- Volume
- 295
- Issue
- 10
- Pages
- 1135
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1972508135
- Cited by
- 490
- References
- 52
- Citations by year
- 2026: 22 · 2025: 26 · 2024: 26 · 2023: 21 · 2022: 20 · 2021: 21 · 2020: 24 · 2019: 24 · 2018: 30 · 2017: 30 · 2016: 21 · 2015: 22 · 2014: 28 · 2013: 22 · 2012: 24
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- green
- jamanetwork.com
- Licence
- other-oa
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Investigative News in Education (Universidad de Costa Rica) (submittedVersion)
- Funders
- Harvard University
- Universidad de Costa Rica
- National Heart, Lung, and Blood Institute (HL 60692, HL 071888, R01HL071888, R01HL060692)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- coffee consumption, myocardial infarction, caffeine metabolism, gene-environment interaction, cardiovascular risk, Costa Rica, young adults, hormone replacement therapy
- MeSH terms
- Aged, Catchment Area, Health, Coffee, Costa Rica, Female, Genotype, Humans, Male, Middle Aged, Myocardial Infarction, Polymorphism, Restriction Fragment Length, Risk Factors, Logistic Models, Polymerase Chain Reaction, Cytochrome P-450 CYP1A2, Amino Acid Substitution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review